Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Other financing activities (2010 - 2026)

Emergent BioSolutions (EBS) posted Other financing activities of $1.4 million for Q2 2026, up 275.0% on a QoQ basis from -$800000.0 in Q3 2025, and up 100.0% year-over-year from $700000.0 in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Other financing activities (2010 - 2026) Analysis & Trends

Emergent BioSolutions has reported Other financing activities for 17 years, with the latest figure at $1.4 million in Q2 2026.

  • On a quarterly basis, Other financing activities rose 100.0% year-over-year to $1.4 million in Q2 2026; TTM through Jun 2026 was $600000.0, a 95.56% decrease from a year earlier, with the FY2024 full-year figure at $13.4 million, up 644.44% from the prior year.
  • Other financing activities was $1.4 million for Q2 2026 at Emergent BioSolutions, up from -$800000.0 in the prior quarter.
  • The five-year high for Other financing activities was $12.7 million in Q3 2024, with the low at -$800000.0 in Q3 2025.
  • Average Other financing activities over 5 years is $2.0 million, with a median of $700000.0 recorded in 2024.
  • The sharpest annual moves came in 2025 and 2026: Other financing activities slumped 106.3% in 2025, then soared 100.0% in 2026.
  • Over 5 years, Other financing activities stood at $2.0 million in 2022, then slumped by 75.0% to $500000.0 in 2023, then surged by 2440.0% to $12.7 million in 2024, then tumbled by 106.3% to -$800000.0 in 2025, then jumped by 275.0% to $1.4 million in 2026.
  • The last three Other financing activities figures came in at $1.4 million (Q2 2026), -$800000.0 (Q3 2025), and $700000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn
9 Revolution Medicines 41.30 Bn 41.30 Bn -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.40 Mn
Sep 30, 2025 -800,000.00
Jun 30, 2025 700,000.00
Mar 31, 2025 100,000.00
Sep 30, 2024 12.70 Mn
Jun 30, 2024 700,000.00
Dec 31, 2023 500,000.00
Jun 30, 2023 1.30 Mn
Dec 31, 2022 2.00 Mn
Jun 30, 2022 2.50 Mn
Mar 31, 2022 500,000.00
Dec 31, 2021 3.40 Mn
Sep 30, 2021 2.50 Mn
Jun 30, 2021 3.10 Mn
Mar 31, 2021 6.90 Mn
Dec 31, 2020 5.00 Mn
Sep 30, 2020 3.50 Mn
Jun 30, 2020 14.00 Mn
Mar 31, 2020 9.10 Mn
Dec 31, 2019 2.50 Mn
API Access

Emergent BioSolutions Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=EBS&period=max&api_key=YOUR_API_KEY